This grand round has already taken place.
Urology Tumor Board meets to discuss individual patients' diagnosis, staging, and treatment options in order to determine the best course of action.
This meeting will include discussions about a patient with a history of bladder cancer, now with pelvic mass, s/p urethral biopsy and imaging; a patient with a history of Tuberous Sclerosis, s/p Left Nephrectomy, now presents with Right renal mass; A patient with intermediate risk - Gleason 7 Prostate Cancer, discuss treatment options; A patient with Prostate Cancer - intermediate risk; a patient with newly diagnosed bladder cancer - need to review path and imaging; A patient with Gleason 4+4, PSA 4.62 (DT ~3 years). Question of ADT/RT vs RALP. Concern for possible T3 disease on MRI.
This meeting is restricted to Stony Brook Affiliates only.
Dates and Times
Start: 10/22/2019 7:30 AM
End: 10/22/2019 8:30 AM
- Interdisciplinary panel with case studies
- Presentation of diagnostic workup
- Prognostic indicators
- Working stage
- Clinical guidelines
- Research protocols
- Treatment planning
- Recommendations for practice
Stony Brook Medicine
100 Nicolls Rd ,Department of Pathology Conference Room, Level 2 Hospital - meets here the 2nd Tuesday of the month
100 Nicolls Rd, Department of Urology Conference Room, Level 9 HSC, Room 040 - meets here the 4th Tuesday of the month
Stony Brook, NY 11794
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.